Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-anal...
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
There is an increasing number of papers reporting the real world use of Nusinersen in different cohorts of SMA patients. Our review suggests that Nusinersen provides a favorable benefit in motor function across a wide range of SMA type 2 and 3 patients over a 10-14 month observation period. Although a direct comparison with studies reporting data f...
Alternative Titles
Full title
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7052ee4c081f4655ba5496e0f865c713
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7052ee4c081f4655ba5496e0f865c713
Other Identifiers
ISSN
1750-1172
E-ISSN
1750-1172
DOI
10.1186/s13023-021-02065-z
